Biofabrication最新文献

筛选
英文 中文
Biotechnological advances in 3D modeling of cancer initiation. Examples from pancreatic cancer research and beyond. 癌症起始三维建模的生物技术进展。来自胰腺癌研究的例子。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-28 DOI: 10.1088/1758-5090/adb51c
C Handschin, H Shalhoub, A Mazet, C Guyon, N Dusserre, E Boutet-Robinet, H Oliveira, J Guillermet-Guibert
{"title":"Biotechnological advances in 3D modeling of cancer initiation. Examples from pancreatic cancer research and beyond.","authors":"C Handschin, H Shalhoub, A Mazet, C Guyon, N Dusserre, E Boutet-Robinet, H Oliveira, J Guillermet-Guibert","doi":"10.1088/1758-5090/adb51c","DOIUrl":"10.1088/1758-5090/adb51c","url":null,"abstract":"<p><p>In recent years, biofabrication technologies have garnered significant attention within the scientific community for their potential to create advanced<i>in vitro</i>cancer models. While these technologies have been predominantly applied to model advanced stages of cancer, there exists a pressing need to develop pertinent, reproducible, and sensitive 3D models that mimic cancer initiation lesions within their native tissue microenvironment. Such models hold profound relevance for comprehending the intricacies of cancer initiation, to devise novel strategies for early intervention, and/or to conduct sophisticated toxicology assessments of putative carcinogens. Here, we will explain the pivotal factors that must be faithfully recapitulated when constructing these models, with a specific focus on early pancreatic cancer lesions. By synthesizing the current state of research in this field, we will provide insights into recent advances and breakthroughs. Additionally, we will delineate the key technological and biological challenges that necessitate resolution in future endeavors, thereby paving the way for more accurate and insightful<i>in vitro</i>cancer initiation models.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":"17 2","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143522587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating biomechanics as a key evaluation metric for organoids. 将生物力学作为类器官的关键评价指标。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-27 DOI: 10.1088/1758-5090/adb802
Jishizhan Chen
{"title":"Incorporating biomechanics as a key evaluation metric for organoids.","authors":"Jishizhan Chen","doi":"10.1088/1758-5090/adb802","DOIUrl":"10.1088/1758-5090/adb802","url":null,"abstract":"","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143456643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application progress of bio-manufacturing technology in kidney organoids. 生物制造技术在肾类器官中的应用进展。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-27 DOI: 10.1088/1758-5090/adb4a1
Runqi Mao, Junming Zhang, Haoxiang Qin, Yuanyuan Liu, Yuxin Xing, Wen Zeng
{"title":"Application progress of bio-manufacturing technology in kidney organoids.","authors":"Runqi Mao, Junming Zhang, Haoxiang Qin, Yuanyuan Liu, Yuxin Xing, Wen Zeng","doi":"10.1088/1758-5090/adb4a1","DOIUrl":"10.1088/1758-5090/adb4a1","url":null,"abstract":"<p><p>Kidney transplantation remains a pivotal treatment modality for kidney disease, yet its progress is significantly hindered by the scarcity of donor kidneys and ethical dilemmas surrounding their procurement. As organoid technology evolves and matures, the creation of bionic human kidney organoids offers profound potential for advancing kidney disease research, drug nephrotoxicity screening, and regenerative medicine. Nevertheless, current kidney organoid models grapple with limitations such as constrained cellular differentiation, underdeveloped functional structures, and a crucial absence of vascularization. This deficiency in vascularization, in particular, stunts organoid development, restricts their size, diminishes filtration capabilities, and may trigger immune inflammatory reactions through the resulting ischemic microenvironment. Hence, the achievement of vascularization within kidney organoids and the successful establishment of functional microvascular networks constitutes a paramount goal for their future progression. In this review, we provide an overview of recent advancements in biotechnology domains, encompassing organ-on-a-chip technology, biomimetic matrices, and bioprinting, with the aim of catalyzing technological breakthroughs that can enhance the vascularization of kidney organoids and broaden their applicability. These technologies hold the key to unlocking the full potential of kidney organoids as a transformative therapeutic option for kidney disease.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143398035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing regenerative medicine: the Aceman system's pioneering automation and machine learning in mesenchymal stem cell biofabrication. 推进再生医学:Aceman系统在间充质干细胞生物制造方面的开创性自动化和机器学习。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-27 DOI: 10.1088/1758-5090/adb803
Kai Zhu, Yi Ding, Yuqiang Chen, Kechuan Su, Jintu Zheng, Yu Zhang, Ying Hu, Jun Wei, Zenan Wang
{"title":"Advancing regenerative medicine: the Aceman system's pioneering automation and machine learning in mesenchymal stem cell biofabrication.","authors":"Kai Zhu, Yi Ding, Yuqiang Chen, Kechuan Su, Jintu Zheng, Yu Zhang, Ying Hu, Jun Wei, Zenan Wang","doi":"10.1088/1758-5090/adb803","DOIUrl":"10.1088/1758-5090/adb803","url":null,"abstract":"<p><p>Mesenchymal stem cells (MSCs) are pivotal in advancing regenerative medicine; however, the large-scale production of MSCs for clinical applications faces significant challenges related to efficiency, cost, and quality assurance. We introduce the Automated Cell Manufacturing System (Aceman), a revolutionary solution that leverages machine learning and robotics integration to optimize MSC production. This innovative system enhances both efficiency and quality in the field of regenerative medicine. With a modular design that adheres to good manufacturing practice standards, Aceman allows for scalable adherent cell cultures. A sophisticated machine learning algorithm has been developed to streamline cell counting and confluence assessment, while the accompanying control software features customization options, robust data management, and real-time monitoring capabilities. Comparative studies reveal that Aceman achieves superior efficiency in analytical and repeatable tasks compared to traditional manual methods. The system's continuous operation minimizes human error, offering substantial long-term benefits. Comprehensive cell biology assays, including Bulk RNA-Seq analysis and flow cytometry, support that the cells produced by Aceman function comparably to those cultivated through conventional techniques. Importantly, Aceman maintains the characteristic immunophenotype of MSCs during automated subcultures, representing a significant advancement in cell production technology. This system lays a solid foundation for future innovations in healthcare biomanufacturing, ultimately enhancing the potential of MSCs in therapeutic applications.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143456638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-time assessment of cell concentration and viability onboard a syringe using dielectric impedance spectroscopy for extrusion bioprinting. 利用介电阻抗谱实时评估注射器上细胞浓度和活力,用于挤出生物打印。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-25 DOI: 10.1088/1758-5090/adb4a4
Alicia A Matavosian, Alexandra C Griffin, Didarul B Bhuiyan, Alexander M Lyness, Vivek Bhatnagar, Lawrence J Bonassar
{"title":"Real-time assessment of cell concentration and viability onboard a syringe using dielectric impedance spectroscopy for extrusion bioprinting.","authors":"Alicia A Matavosian, Alexandra C Griffin, Didarul B Bhuiyan, Alexander M Lyness, Vivek Bhatnagar, Lawrence J Bonassar","doi":"10.1088/1758-5090/adb4a4","DOIUrl":"10.1088/1758-5090/adb4a4","url":null,"abstract":"<p><p>Bioprinting produces personalized, cell-laden constructs for tissue regeneration through the additive layering of bio-ink, an injectable hydrogel infused with cells. Currently, bioprinted constructs are assessed for quality by measuring cellular properties post-production using destructive techniques, necessitating the creation of multiple constructs and increasing the production costs of bioprinting. To reduce this burden, cell properties in bio-ink can be monitored in real-time during printing. We incorporated dielectric impedance spectroscopy (DIS) onto a syringe for real-time measurement of primary chondrocytes suspended in phosphate buffered saline (PBS) using impedance (|<i>Z</i>|) and phase angle (<i>θ</i>) from 0.1 to 25 000 kHz. Cell concentration and viability ranged from 0.1 × 10<sup>6</sup>cells ml<sup>-1</sup>to 125 × 10<sup>6</sup>cells ml<sup>-1</sup>and from 0%to 94%, respectively. Samples with constant or with changing cell concentration were exposed to various flow conditions from 0.5 to 4 ml min<sup>-1</sup>. The background PBS signal was subtracted from the sample, allowing for comparisons across devices and providing insight into the dielectric properties of the cells, and was labeled as |<i>Z<sub>cells</sub></i>| and<i>θ<sub>cells</sub></i>. |<i>Z<sub>cells</sub></i>| shared a linear correlation with cell concentration and viability. Flow rate had minimal effect on our results, and |<i>Z<sub>cells</sub></i>| responded on the order of seconds as cell concentration was altered over time. Notably, sensitivity to cell concentration and viability were dependent on frequency and were highest for |<i>Z<sub>cells</sub></i>| when<i>θ<sub>cells</sub></i>was minimized. Cell concentration and viability showed an additive effect on |<i>Z<sub>cells</sub></i>| that was modeled across multiple frequencies, and deconvolution of these signals could result in real-time predictions of cell properties in the future. Overall, DIS was found to be a suitable technique for real-time sensing of cell concentration and viability during bioprinting.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143398038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cell-based drug screening assay on a centrifugal platform. 离心平台上基于细胞的药物筛选试验。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-25 DOI: 10.1088/1758-5090/adb4a2
Chia-Tse Shih, Huan-Jun Guo, Chih-Hsin Shih, Yi-Chen Ethan Li
{"title":"A cell-based drug screening assay on a centrifugal platform.","authors":"Chia-Tse Shih, Huan-Jun Guo, Chih-Hsin Shih, Yi-Chen Ethan Li","doi":"10.1088/1758-5090/adb4a2","DOIUrl":"10.1088/1758-5090/adb4a2","url":null,"abstract":"<p><p>Drug screening is an indispensable procedure in drug development and pharmaceutical research. For cell-based drug testing, cells were treated with compounds at different concentrations, and their responses were measured to assess the compounds' effects on cellular behavior. A concentration gradient test creates a growth environment with different compound concentrations for cultured cells, facilitating faster determination of the compound concentration's effect on cellular responses. However, most concentration gradient tests on cell cultures were carried out manually, which is labor-intensive and time-consuming. Microfluidic technology enables drug screening to be conducted in microstructures, which not only improves efficiency and sensitivity but also reduces reagent usage and operating time. Centrifugal microfluidics utilizes the rotation of a disk platform to perform complex fluid functions such as pumping, metering, and mixing. The complete process can be carried out with a low-cost motor without the need for an expensive pumping system. In this work, a centrifugal platform for drug screening is presented. The microfluidic platform can be divided into two parts. The inner disk features branch structures designed to establish a concentration gradient for cell growth. The outer ring contains fluidics for cell culturing, which can discharge the waste fluid when the nutrient is exhausted and replenish the new culture medium by spinning the platform. In conclusion, the proposed centrifugal platform can provide a rapid generation of the concentration gradients and automate the operation of cell culturing. It provides an efficient and low-cost platform for drug screening.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143398032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A micro-lung chip with macrophages for targeted anti-fibrotic therapy. 靶向抗纤维化治疗的巨噬细胞微肺芯片。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-25 DOI: 10.1088/1758-5090/adb338
Jingjing Xia, Ruming Dong, Yongcong Fang, Jiabin Guo, Zhuo Xiong, Ting Zhang, Wei Sun
{"title":"A micro-lung chip with macrophages for targeted anti-fibrotic therapy.","authors":"Jingjing Xia, Ruming Dong, Yongcong Fang, Jiabin Guo, Zhuo Xiong, Ting Zhang, Wei Sun","doi":"10.1088/1758-5090/adb338","DOIUrl":"10.1088/1758-5090/adb338","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology. Macrophages are implicated in the fibrotic process, but exhibit remarkable plasticity in the activated immune environment<i>in vivo</i>, presenting significant challenges as therapeutic targets. To explore the influence of macrophages on IPF and develop macrophage-targeted therapies, we engineered a micro-lung chip with a lung epithelium-interstitium tissue unit to establish a controlled immune environment containing only macrophages. We discovered that macrophages exacerbated inflammation and fibrosis by comparing microchips treated with bleomycin (BLM) in the presence and absence of macrophages. Based on the duration of BLM treatment, we established pathological models corresponding to inflammation and fibrosis stages. Transcriptome analysis revealed that activation of the PI3K-AKT signalling pathway facilitates the transition from inflammation to fibrosis. However, LY294002, a PI3K inhibitor, not only suppressed fibrosis and decreased the accumulation of M2 macrophages but also intensified the severity of inflammation. These findings suggest that macrophages play a pivotal role in the potential development at the tissue level. The micro-lung chip co-cultured with macrophages holds significant potential for exploring the pathological progression of IPF and elucidating the mechanisms of anti-fibrotic drugs.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143363552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Support-less 3D bioceramic/extracellular matrix printing in sanitizer-based hydrogel for bone tissue engineering. 用于骨组织工程的基于消毒液的水凝胶无支撑3D生物陶瓷/细胞外基质打印。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-21 DOI: 10.1088/1758-5090/adb4a3
Siwi Setya Utami, Naren Raja, Jueun Kim, Imam Akbar Sutejo, Honghyun Park, Aram Sung, Changwoo Gal, Hui-Suk Yun, Yeong-Jin Choi
{"title":"Support-less 3D bioceramic/extracellular matrix printing in sanitizer-based hydrogel for bone tissue engineering.","authors":"Siwi Setya Utami, Naren Raja, Jueun Kim, Imam Akbar Sutejo, Honghyun Park, Aram Sung, Changwoo Gal, Hui-Suk Yun, Yeong-Jin Choi","doi":"10.1088/1758-5090/adb4a3","DOIUrl":"10.1088/1758-5090/adb4a3","url":null,"abstract":"<p><p>To meet the increasing demand for bone scaffolds, advancements in 3D printing have significantly impacted bone tissue engineering. However, the materials used must closely mimic the biological components and structural characteristics of natural bone tissue. Additionally, constructing complex, oblique structures presents considerable challenges. To address these issues, we explored 3D bioceramic printing using a sanitizer-based hydrogel. Collagen, a primary component of the bone extracellular matrix (ECM), was combined with alpha-tricalcium phosphate (<i>α</i>-TCP) to create the bioceramic ink. The sanitizer-based hydrogel was chosen as the gel bath due to its carbopol content, which provides hydrogel-like support, and ethanol, which coagulates collagen and maintains the integrity of the 3D-printed structure. The<i>α</i>-TCP/collagen bioceramic ink was printed within the sanitizer-based hydrogel, then collected, immersed in ethanol, and finally submerged in phosphate-buffer saline to initiate a self-setting reaction that converted<i>α</i>-TCP into calcium-deficient hydroxyapatite. The results demonstrated that complex ceramic/ECM structures could be successfully printed in the sanitizer bath, exhibiting excellent mechanical characteristics. Additionally, scaffolds printed in the sanitizer bath showed higher levels of cell growth and osteogenic activity compared to those produced with only<i>α</i>-TCP in an open-air environment. This bioceramic printing approach has a strong potential for constructing complex scaffolds with enhanced osteogenic potential for bone regeneration.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143398042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valorization of crop by-products into bio-based dental materials: advancements and prospects. 农作物副产品转化为生物基牙科材料:进展与展望。
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-18 DOI: 10.1088/1758-5090/ada736
Marcin Mikulewicz, Katarzyna Chojnacka
{"title":"Valorization of crop by-products into bio-based dental materials: advancements and prospects.","authors":"Marcin Mikulewicz, Katarzyna Chojnacka","doi":"10.1088/1758-5090/ada736","DOIUrl":"10.1088/1758-5090/ada736","url":null,"abstract":"<p><p>The objective of this review is to deepen understanding and emphasize scientific and technological progress in the transformation of crop by-products into bio-based dental materials. Amid heightened environmental sustainability consciousness, various sectors including dentistry have achieved novel advancements by utilizing bio-based materials from crop by-products for dental restorations. This paper provides a thorough review of the extraction, processing, and application of natural polymers, biopolymers, and bio-based mixtures at both the macroscopic and nanoscopic scales, with a focus on their contextualization within dental practices. The performance and efficacy of bio-resins, bio-sourced monomers, and biopolymers derived from these resources were scrutinized and compared with traditional petroleum-based counterparts. This study addresses the recycling and industrial valorization of bio-based dental materials, emphasizing their potential to foster a circular economy in dentistry.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rational design of 3D-printed scaffolds for breast tissue engineering using structural analysis. 基于结构分析的乳腺组织工程3d打印支架的合理设计
IF 8.2 2区 医学
Biofabrication Pub Date : 2025-02-17 DOI: 10.1088/1758-5090/adaf5a
Sharon Kracoff-Sella, Idit Goldfracht, Asaf Silverstein, Shira Landau, Lior Debbi, Rita Beckerman, Hagit Shoyhat, Yifat Herman-Bachinsky, Gali Guterman-Ram, Inbal Michael, Rita Shuhmaher, Janette Zavin, Ronen Ben Horin, Dana Egozi, Shulamit Levenberg
{"title":"Rational design of 3D-printed scaffolds for breast tissue engineering using structural analysis.","authors":"Sharon Kracoff-Sella, Idit Goldfracht, Asaf Silverstein, Shira Landau, Lior Debbi, Rita Beckerman, Hagit Shoyhat, Yifat Herman-Bachinsky, Gali Guterman-Ram, Inbal Michael, Rita Shuhmaher, Janette Zavin, Ronen Ben Horin, Dana Egozi, Shulamit Levenberg","doi":"10.1088/1758-5090/adaf5a","DOIUrl":"10.1088/1758-5090/adaf5a","url":null,"abstract":"<p><p>Best cosmetic outcomes of breast reconstruction using tissue engineering techniques rely on the scaffold architecture and material, which are currently both to be determined. This study suggests an approach for a rational design of breast-shaped scaffold architecture, in which structural analysis is implemented to predict its stiffness and adjust it to that of the native tissue. This approach can help achieve the goal of optimal scaffold architecture for breast tissue engineering. Based on specifications defined in a preliminary implantation study of a non-rationally designed scaffold, and using analytical modeling and finite element analysis, we rationally designed a polycaprolactone made, 3D-printed, highly porous, breast-shaped scaffold with a stiffness similar to the breast adipose tissue. This scaffold had an architecture of a double-shelled dome connected by pillars, with no bottom to allow direct contact of its fat graft with the host's blood vessels (shelled hemisphere adaptive design (SHAD)). To demonstrate the potential of the SHAD scaffold in breast tissue engineering, a proof-of-concept study was performed, in which SHAD scaffolds were embedded with human adipose derived mesenchymal stem cells, isolated from lipoaspirates, and implanted in nod-scid-gamma mouse model with a delayed fat graft injection. After 4 weeks of implantation, the SHAD implants were vascularized with a viable fat graft, indicating the suitability of the SHAD scaffold for breast tissue engineering.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信